UPDATED May 28, 2024
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
LVRO | US$5.94 | 3.3% | 2.6% | US$660.0m | US$10.00 | PB2x | S19.0% | n/a | ||
HYZN | US$0.50 | -3.2% | -17.6% | US$125.2m | US$1.60 | PS12x | E13.0% | n/a | ||
MIDD | US$123.09 | -7.4% | -9.0% | US$6.7b | US$160.00 | PE17x | E10.8% | n/a | ||
PRIM | US$54.84 | 4.7% | 98.0% | US$2.9b | US$56.60 | PE20.5x | E17.5% | 0.4% | ||
LMT | US$458.48 | -2.1% | 2.3% | US$112.1b | US$488.84 | PE16.2x | E0.9% | 2.7% | ||
DE | US$369.27 | -4.5% | 5.3% | US$104.4b | US$420.65 | PE10.9x | E-7.5% | 1.6% | ||
HUBB | US$389.28 | -3.0% | 37.8% | US$21.3b | US$404.46 | PE28.9x | E9.0% | 1.3% | ||
HEES | US$46.99 | -3.0% | 30.7% | US$1.7b | US$65.80 | PE10x | E3.5% | 2.3% | ||
IEP | US$16.36 | -1.0% | -27.5% | US$7.5b | US$25.00 | PB2.1x | E130.8% | 24.4% | ||
CNH | US$10.51 | -4.6% | -18.1% | US$13.4b | US$14.92 | PE5.8x | E-2.7% | 4.5% | ||
ZKH | US$8.91 | -16.5% | n/a | US$1.5b | US$18.34 | PS1.2x | E102.8% | n/a | ||
SHYF | US$12.56 | -1.6% | -47.9% | US$430.7m | US$13.00 | PE3690.1x | E131.9% | 1.6% | ||
VMI | US$251.41 | -2.2% | -7.4% | US$5.1b | US$288.33 | PE32.4x | E39.4% | 1.0% | ||
SPXC | US$141.99 | -1.6% | 84.3% | US$6.7b | US$150.60 | PE42.4x | E27.1% | 0% | ||
CSL | US$421.42 | -1.3% | 95.2% | US$20.3b | US$432.06 | PE24.9x | E6.2% | 0.8% | ||
AULT | US$0.36 | -23.2% | -99.9% | US$11.3m | n/a | PB0.2x | n/a | n/a | ||
NOC | US$455.50 | -3.5% | 4.0% | US$69.0b | US$501.52 | PE31.2x | E14.0% | 1.6% | ||
SOL | US$1.85 | -6.6% | -45.6% | US$102.3m | US$4.88 | PB0.3x | E124.6% | n/a | ||
GLDD | US$8.99 | -2.4% | 41.8% | US$618.5m | US$12.50 | PE15.8x | E20.8% | 0% | ||
RAYA | US$0.93 | 12.0% | -51.6% | US$10.9m | US$4.67 | PE9.2x | S26.3% | n/a | ||
FERG | US$203.53 | -3.1% | 40.5% | US$41.5b | US$216.20 | PE23.3x | E8.6% | 1.6% | ||
MAS | US$67.33 | -2.8% | 39.3% | US$14.9b | US$80.02 | PE16.2x | E5.1% | 1.7% | ||
CDRE | US$32.60 | 2.2% | 56.0% | US$1.4b | US$42.17 | PE34.3x | E17.6% | 1.1% |